Listed

Option Care Health, Inc.

OPCHNasdaqCIK 1014739HealthcareFiscal year ends Dec 31

Latest reported revenue, Q1 FY2026$1.35bnRevenue, Q1 FY2026, three months to 2026-03-31$1.35bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figureThree months to Mar 31, 2026, from the 10-Q filed Apr 30, 2026.

Latest quarter: Q1 FY2026

Three months to Mar 31, 2026, against the same quarter a year earlier.

  • Revenue$1.35bnRevenue, Q1 FY2026, three months to 2026-03-31$1.35bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure+1.3% on a year earlier
  • Gross margin19.4%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $262.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Revenue: $1.35bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure−0.3 pts on a year earlier
  • Operating margin5.4%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $72.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Revenue: $1.35bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure−0.6 pts on a year earlier
  • Net margin3.4%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $45.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Revenue: $1.35bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure−0.1 pts on a year earlier
  • Diluted EPS$0.29Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure+3.6% on a year earlier
  • Free cash flow−$21.2mFree cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$12.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Capital expenditure: $9.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure−27.6% on a year earlier

Last eight quarters

Full statements
Revenue$1.35bnGross margin 19.4%
Diluted EPS$0.29, Q1 FY2026
Free cash flow−$21.2m, Q1 FY2026
Option Care Health, Inc., key figures for the last eight quarters
Line itemUnitQ2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Shape over the periods
Revenue$m1,227Revenue, Q2 FY2024, three months to 2024-06-30$1.23bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0001014739-25-000037.Report this figure1,279Revenue, Q3 FY2024, three months to 2024-09-30$1.28bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Report this figure1,346Revenue, Q4 FY2024, three months to 2024-12-31$1.35bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure1,333Revenue, Q1 FY2025, three months to 2025-03-31$1.33bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure1,416Revenue, Q2 FY2025, three months to 2025-06-30$1.42bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0001014739-25-000037.Report this figure1,435Revenue, Q3 FY2025, three months to 2025-09-30$1.44bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Report this figure1,465Revenue, Q4 FY2025, three months to 2025-12-31$1.47bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure1,351Revenue, Q1 FY2026, three months to 2026-03-31$1.35bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure
Gross margin%20.3%Gross margin, Q2 FY2024, three months to 2024-06-30. gross profit / revenueGross profit: $249.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-07-30, accession 0001014739-25-000037.Revenue: $1.23bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0001014739-25-000037.Report this figure20.1%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $256.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Revenue: $1.28bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Report this figure19.9%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $268.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Revenue: $1.35bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure19.7%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $263.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Revenue: $1.33bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure19.0%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $269.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-07-30, accession 0001014739-25-000037.Revenue: $1.42bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0001014739-25-000037.Report this figure19.0%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $272.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Revenue: $1.44bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Report this figure19.3%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $282.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Revenue: $1.47bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure19.4%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $262.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Revenue: $1.35bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure
Operating margin%6.6%Operating margin, Q2 FY2024, three months to 2024-06-30. operating income / revenueOperating income: $80.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-30, accession 0001014739-25-000037.Revenue: $1.23bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0001014739-25-000037.Report this figure6.7%Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: $85.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Revenue: $1.28bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Report this figure6.5%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $87.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Revenue: $1.35bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure5.9%Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: $79.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Revenue: $1.33bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure5.8%Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: $82.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-30, accession 0001014739-25-000037.Revenue: $1.42bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0001014739-25-000037.Report this figure5.9%Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: $84.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Revenue: $1.44bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Report this figure6.2%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $91.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Revenue: $1.47bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure5.4%Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: $72.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Revenue: $1.35bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure
Net margin%4.3%Net margin, Q2 FY2024, three months to 2024-06-30. net income / revenueNet income: $53.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Revenue: $1.23bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0001014739-25-000037.Report this figure4.2%Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: $53.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Revenue: $1.28bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Report this figure4.5%Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: $60.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Revenue: $1.35bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure3.5%Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: $46.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Revenue: $1.33bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure3.6%Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: $50.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Revenue: $1.42bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-07-30, accession 0001014739-25-000037.Report this figure3.6%Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: $51.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Revenue: $1.44bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Report this figure4.0%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $58.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Revenue: $1.47bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure3.4%Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: $45.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Revenue: $1.35bn. XBRL concept us-gaap:Revenues. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure
Diluted EPS$ per share0.30Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-30, accession 0001014739-25-000037.Report this figure0.31Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Report this figurenot reported (Diluted EPS not reported)0.28Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure0.31Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-30, accession 0001014739-25-000037.Report this figure0.32Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001014739-25-000046.Report this figurenot reported (Diluted EPS not reported)0.29Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure
Free cash flow$m186Free cash flow, Q2 FY2024, three months to 2024-06-30. operating cash flow − capital expenditureOperating cash flow: $195.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-30, accession 0001014739-25-000037. Derived: 6-month figure less the 3-month figure.Capital expenditure: $9.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-30, accession 0001014739-25-000037. Derived: 6-month figure less the 3-month figure.Report this figure151Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $160.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001014739-25-000046. Derived: 9-month figure less the 6-month figure.Capital expenditure: $9.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001014739-25-000046. Derived: 9-month figure less the 6-month figure.Report this figure25.8Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $36.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Capital expenditure: $10.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(16.6)Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Capital expenditure: $9.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure81.2Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $90.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-30, accession 0001014739-25-000037. Derived: 6-month figure less the 3-month figure.Capital expenditure: $9.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-30, accession 0001014739-25-000037. Derived: 6-month figure less the 3-month figure.Report this figure130Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $139.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001014739-25-000046. Derived: 9-month figure less the 6-month figure.Capital expenditure: $9.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001014739-25-000046. Derived: 9-month figure less the 6-month figure.Report this figure22.2Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $35.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Capital expenditure: $13.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001014739-26-000008. Derived: 12-month figure less the 9-month figure.Report this figure(21.2)Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$12.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Capital expenditure: $9.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-04-30, accession 0001014739-26-000011.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$5.65bnGross margin 19.3%
Diluted EPS$1.27, FY2025
Free cash flow$217.1m, FY2025
Option Care Health, Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m3,439Revenue, FY2021, twelve months to 2021-12-31$3.44bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-22, accession 0001014739-24-000009.Report this figure3,869Revenue, FY2022, twelve months to 2022-12-31$3.87bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-26, accession 0001014739-25-000012.Report this figure4,302Revenue, FY2023, twelve months to 2023-12-31$4.30bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure4,998Revenue, FY2024, twelve months to 2024-12-31$5.00bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure5,650Revenue, FY2025, twelve months to 2025-12-31$5.65bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure
Gross margin%22.7%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $779.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-22, accession 0001014739-24-000009.Revenue: $3.44bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-22, accession 0001014739-24-000009.Report this figure22.4%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $866.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-26, accession 0001014739-25-000012.Revenue: $3.87bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-26, accession 0001014739-25-000012.Report this figure22.8%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $981.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001014739-26-000008.Revenue: $4.30bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure20.3%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $1.01bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001014739-26-000008.Revenue: $5.00bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure19.3%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $1.09bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-24, accession 0001014739-26-000008.Revenue: $5.65bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure
Operating margin%5.5%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $190.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-22, accession 0001014739-24-000009.Revenue: $3.44bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-22, accession 0001014739-24-000009.Report this figure6.2%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $240.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-26, accession 0001014739-25-000012.Revenue: $3.87bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-26, accession 0001014739-25-000012.Report this figure7.3%Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: $314.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001014739-26-000008.Revenue: $4.30bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure6.4%Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: $321.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001014739-26-000008.Revenue: $5.00bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure6.0%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $337.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-24, accession 0001014739-26-000008.Revenue: $5.65bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure
Net margin%4.1%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $139.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-22, accession 0001014739-24-000009.Revenue: $3.44bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-22, accession 0001014739-24-000009.Report this figure3.9%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $150.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-26, accession 0001014739-25-000012.Revenue: $3.87bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-02-26, accession 0001014739-25-000012.Report this figure6.2%Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: $267.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001014739-26-000008.Revenue: $4.30bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure4.2%Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: $211.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001014739-26-000008.Revenue: $5.00bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure3.7%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $207.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001014739-26-000008.Revenue: $5.65bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure
Diluted EPS$ per share0.77Diluted EPS, FY2021, twelve months to 2021-12-31$0.77 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-22, accession 0001014739-24-000009.Report this figure0.83Diluted EPS, FY2022, twelve months to 2022-12-31$0.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-26, accession 0001014739-25-000012.Report this figure1.48Diluted EPS, FY2023, twelve months to 2023-12-31$1.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure1.23Diluted EPS, FY2024, twelve months to 2024-12-31$1.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure1.27Diluted EPS, FY2025, twelve months to 2025-12-31$1.27 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure
Free cash flow$m183Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $208.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-22, accession 0001014739-24-000009.Capital expenditure: $25.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-22, accession 0001014739-24-000009.Report this figure232Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $267.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-26, accession 0001014739-25-000012.Capital expenditure: $35.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-26, accession 0001014739-25-000012.Report this figure329Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $371.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001014739-26-000008.Capital expenditure: $41.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure288Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $323.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001014739-26-000008.Capital expenditure: $35.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure217Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $258.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001014739-26-000008.Capital expenditure: $41.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-24, accession 0001014739-26-000008.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Option Care Health, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$463.5m22,104,863Added+2,217,031
WELLINGTON MANAGEMENT GROUP LLP2026-06-30$247.1m11,782,384Reduced−115,083
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$173.5m8,274,458Added+211,903
FULLER & THALER ASSET MANAGEMENT, INC.2026-06-30$156.2m7,450,698Added+325,418
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$148.1m7,063,747Added+47,424
Durable Capital Partners LP2026-06-30$129.3m6,163,722Reduced−2,827,532
STATE STREET CORP2026-06-30$128.8m6,139,898Added+265,018
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP2026-06-30$125.4m5,980,270Added+1,744,033
DIMENSIONAL FUND ADVISORS LP2026-06-30$114.3m5,449,294Added+1,572,438
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$93.7m4,467,797Added+219,576

Recent filings

All 1,372 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Option Care Health, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-0608:22 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-26-113904
2026-07-2907:26 ET10-QQuarterly reportPeriod 2026-06-300001014739-26-000023
2026-07-2906:56 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001014739-26-000021
2026-05-2216:00 ET8-K5.07 Shareholder vote results0001014739-26-000017
2026-05-1207:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-26-058979
2026-05-0516:01 ET8-K5.02 Departure or appointment of officers or directors0001014739-26-000014
2026-04-3016:00 ET10-QQuarterly reportPeriod 2026-03-310001014739-26-000011
2026-04-3007:01 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-26-052099
2026-04-0816:15 ETDEF 14AProxy statementPeriod 2026-05-200001140361-26-013825
2026-04-0216:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001104659-26-039171

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 24, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
1014739
Tickers
OPCH
Exchange
Nasdaq
SIC code
8082 Services-Home Health Care Services
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Large accelerated filer
Former names
BioScrip, Inc. (to 2019-08-02); MIM CORP (to 2005-03-14)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:18 ET. Listed shows no prices and gives no investment advice.